MELE.BR · PEAD → 0

Melexis reported Q2 2026 EPS of €0.76 on 2026-07-29, beating the €0.73 consensus by €0.03 (+4.1%); no prior-year EPS comparison is available in the current data feed.

Print-day reaction was −2.5% versus the prior close, a notable sell-the-news move despite the consensus beat. The overnight gap to the T+1 open extended losses by a further −0.6%, suggesting no after-hours recovery. Over the following two trading sessions the price drifted +0.3%, a negligible reversal that left the stock essentially flat from T+1. Cumulative abnormal return of −2.0% versus SPY.US falls within the −3% to +3% neutral band, yielding a PEAD direction of none with zero conviction; no drift trade is signalled through 2026-10-26.